Calcagno Anna Maria, Kim In-Wha, Wu Chung-Pu, Shukla Suneet, Ambudkar Suresh V
Laboratory of Cell Biology, Center for Cancer Research, National Cancer Institute, NIH/DHHS, Bethesda, MD 20892, USA.
Curr Drug Deliv. 2007 Oct;4(4):324-33. doi: 10.2174/156720107782151241.
ABC transporters play an important role in mediating the cytoplasmic concentration of endogenous and xenobiotic substances. They therefore influence the pharmacokinetic profile of a variety of drugs. By virtue of their localization to plasma membranes in the intestine, liver, blood-brain and other vital biological barriers, a majority of ABC drug transporters cause drug-drug interactions, decreased drug efficacy and multidrug resistance for chemotherapeutic agents. Thus, elucidating which drug entities are substrates for ABC drug transporters is a crucial step in the drug development and treatment process. Here, we review the current status of methodology used to categorize drug compounds as substrates or modulators for the major ABC drug transporters including ABCB1, ABCC1 and ABCG2.
ABC转运蛋白在介导内源性和外源性物质的胞质浓度方面发挥着重要作用。因此,它们会影响多种药物的药代动力学特征。由于它们定位于肠道、肝脏、血脑屏障及其他重要生物屏障的质膜上,大多数ABC药物转运蛋白会导致药物相互作用、降低药物疗效以及引发化疗药物的多药耐药性。因此,阐明哪些药物实体是ABC药物转运蛋白的底物是药物研发和治疗过程中的关键一步。在此,我们综述了用于将药物化合物归类为主要ABC药物转运蛋白(包括ABCB1、ABCC1和ABCG2)的底物或调节剂的方法的现状。